Calculus VCT plc (CLC) Ord GBP0.01
Sell:50.00p
Buy:70.00p
0
Change:
No change
No change
Market closed |
Prices as at close on 17 July 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
- Add to watchlist
- This stock can be held in a
Sell:50.00p
Buy:70.00p
Change:
No change
No change
Market closed |
Prices as at close on 17 July 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Sell:50.00p
Buy:70.00p
Change:
No change
No change
Market closed |
Prices as at close on 17 July 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Objective
The Company invests, primarily, in a diversified portfolio of VCT qualifying UK growth companies, whether unquoted or traded on AIM. Investments are made selectively across a range of sectors in companies that have the potential for long-term growth. Our investment is intended to support those companies to grow, innovate and scale up.
| Security | Weight |
|---|---|
| Fidelity ILF - GBP A Acc | 7.79% |
| abrdn Liquidity-Sterling Fund L-3 IncGBP | 7.49% |
| Home Team Content Limited | 4.58% |
| Oxford Bio Therapeutics Limited | 4.19% |
| Brouhaha Entertainment Limited | 4.18% |
| Wheel Right Limited | 4.06% |
| Wazoku Limited | 4.06% |
| Rota Geek Limited | 3.99% |
| Riff Raff Entertainment Limited | 3.96% |
| Mip Diagnostics Limited | 2.80% |
Top 10 sectors currently unavailable.
| Country | Weight |
|---|---|
| United Kingdom | 5.54% |
| Luxembourg | 0.26% |
| Canada | 0.11% |
| Australia | 0.10% |
Fee Structure
Management fee 1.75% p.a. of NAV. Performance fee is 20% of excess cumulative realised gains if certain performance hurdles are achieved. Contract terminable on 1 years notice.
Dividend Policy
The Board aims to maintain a regular tax free annual dividend equal to 4.5% of NAV mindful of the need to maintain NAV. Cannot be guaranteed. To be declared and paid in February.
ASSET SPLIT
Trust Manager
Not currently available for this investment trust.
Manager Bio
Not currently available for this investment trust.
Board Of Directors
Janice WardChairman, John Glencross, Hemant Mardia, Janine Nicholls
Data policy - All information should be used for indicative purposes only. You should
independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete,
and accepts no responsibility for how it may be used.
Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.